ENGN
#3885
enGene Therapeutics Inc. - Common Stock
1.8 6 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.11%
Monthly Change
+6.29%
6 month change
-79.74%
Year Change
-77.86%
Previous Close
1.9 0
Open
1.8 6
Low
1.8 6
High
1.8 6
Volume
19
Financials
- Market Capitalization 124.6 M
- Employee 82
- Founded N/A
- CEO N/A
- Website www.engene.com
- Headquarter Canada (Federal Level)
- FIGI BBG01J1GCYW7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3879 |  SPRO Spero Therapeutics, Inc. - Common Stock | 2.18 USD | +3.81% | +0.93% | -25.60% | -16.48% | 126.23 M USD | ||
| 3884 |  CUE Cue Biopharma, Inc. - Common Stock | 30.92 USD | -15.93% | -5.93% | +26.05% | +3968.42% | 125.09 M USD | ||
| 3888 |  VTVT vTv Therapeutics Inc. - Class A Common Stock | 31.58 USD | -5.70% | -9.36% | -5.62% | +54.05% | 124.39 M USD | ||
| 3895 |  VANI Vivani Medical, Inc. - Common Stock | 1.42 USD | +4.41% | +7.58% | +25.66% | -5.33% | 122.45 M USD |
Frequently asked questions about enGene Therapeutics Inc. - Common Stock
What is the enGene Therapeutics Inc. - Common Stock stock price today?
The current price of enGene Therapeutics Inc. - Common Stock (ENGN) is 1.8599999999999999. Over the past 24 hours, the stock has changed by -2.11%. Follow the ENGN chart for real-time price dynamics.
What is the stock ticker of enGene Therapeutics Inc. - Common Stock?
enGene Therapeutics Inc. - Common Stock trades under the ticker ENGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is enGene Therapeutics Inc. - Common Stock stock going up?
ENGN has changed by -2.62% over the last week, +6.29% over the last month, and -77.86% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does enGene Therapeutics Inc. - Common Stock release financial reports?
Yes. You can track enGene Therapeutics Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was enGene Therapeutics Inc. - Common Stock net income for the last quarter?
enGene Therapeutics Inc. - Common Stock reported net income of -30.23 M for the last quarter. The previous quarter showed -29.75 M, which means net income changed by -1.60%.
How many employees does enGene Therapeutics Inc. - Common Stock have?
As of the latest available data, enGene Therapeutics Inc. - Common Stock has 82 employees. Workforce size can provide additional context about the company's scale and operations.
What is enGene Therapeutics Inc. - Common Stock EBITDA?
enGene Therapeutics Inc. - Common Stock EBITDA is -31.74 M, and its EBITDA margin is -109.44 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy enGene Therapeutics Inc. - Common Stock stock?
You can buy enGene Therapeutics Inc. - Common Stock (ENGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in enGene Therapeutics Inc. - Common Stock stock?
Investing in enGene Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ENGN chart and related analysis on metatrader.com as part of your research.